These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32056186)

  • 41. Efficacy and prognostic analysis of chemoradiotherapy in patients with thoracic esophageal squamous carcinoma with cervical lymph nodal metastasis alone.
    Zhang P; Xi M; Zhao L; Li QQ; He LR; Liu SL; Shen JX; Liu MZ
    Radiat Oncol; 2014 Nov; 9():256. PubMed ID: 25424871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma: clinical outcomes and patterns of failure.
    Cao CN; Luo JW; Gao L; Xu GZ; Yi JL; Huang XD; Wang K; Zhang SP; Qu Y; Li SY; Xiao JP; Zhang Z
    Eur Arch Otorhinolaryngol; 2016 Mar; 273(3):741-7. PubMed ID: 25716773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stricture rate after chemoradiotherapy and radiotherapy for oesophageal squamous cell carcinoma: a 20-year experience.
    Hamer PW; Hight SC; Ward IG; Harris DL; Woodham BL; Flint RS
    ANZ J Surg; 2019 Apr; 89(4):367-371. PubMed ID: 30791194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Minimally Invasive Esophagectomy with Thoracic Duct Resection Post Neoadjuvant Chemoradiotherapy for Carcinoma Esophagus-Impact on Lymph Node Yield and Hemodynamic Parameters.
    Anand S; Kalayarasan R; Chandrasekar S; Gnanasekaran S; Pottakkat B
    J Gastrointest Cancer; 2019 Jun; 50(2):230-235. PubMed ID: 29344808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review.
    Tsou YK; Lee CH; Le PH; Chen BH
    Crit Rev Oncol Hematol; 2020 Mar; 147():102883. PubMed ID: 32014674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
    Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Esophagogastric Preservation in the Surgical Management of Proximal Esophageal Cancer.
    Chow VLY; Chan JYW; Law SYK
    Ann Thorac Surg; 2019 Oct; 108(4):1029-1036. PubMed ID: 31181207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.
    Kumagai K; Mariosa D; Tsai JA; Nilsson M; Ye W; Lundell L; Rouvelas I
    Dis Esophagus; 2016 Oct; 29(7):734-739. PubMed ID: 26316181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Salvage pharyngolaryngectomy with total esophagectomy following definitive chemoradiotherapy.
    Niwa Y; Koike M; Fujimoto Y; Oya H; Iwata N; Nishio N; Hiramatsu M; Kanda M; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Nomoto S; Fujiwara M; Kodera Y
    Dis Esophagus; 2016 Aug; 29(6):598-602. PubMed ID: 26338205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
    Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Salvage surgery in esophageal cancer : Feasibility in patients after definitive radiochemotherapy (> 50 Gy)].
    Schmidt T; Sisic L; Sterzing F; Haag GM; Kunzmann R; Grenacher L; Weichert W; Jäger D; Büchler MW; Ott K
    Chirurg; 2015 Oct; 86(10):955-62. PubMed ID: 25715974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. JMJD3 expression is an independent prognosticator in patients with esophageal squamous cell carcinoma.
    Li SH; Lu HI; Chen YH; Lo CM; Huang WT; Tien WY; Lan YC; Tsai HT; Chen CH
    Surgery; 2019 May; 165(5):946-952. PubMed ID: 30678869
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased Numb protein expression predicts poor clinical outcomes in esophageal squamous cell carcinoma patients.
    Liu Z; Luo C; Yang W; Wang K; Hu C; Zou J; Zhu H; Fu L; Nie J; Cheng C
    Cancer Biol Ther; 2018 Jan; 19(1):34-41. PubMed ID: 28095111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does cervical lymph node recurrence after oesophagectomy or definitive chemoradiotherapy for thoracic oesophageal squamous cell carcinoma benefit from salvage treatment?
    Yuan X; Lv J; Dong H; Wang J
    Interact Cardiovasc Thorac Surg; 2017 May; 24(5):792-795. PubMed ID: 28453803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reply to Letter to the Editor regarding "Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo-)radiotherapy: a systematic review and meta-analysis".
    De Virgilio A; Costantino A; Festa BM; Mercante G; Franceschini D; Franzese C; Scorsetti M; Marrari A; Cavina R; Marano S; Castoro C; Spriano G
    J Cancer Res Clin Oncol; 2023 Mar; 149(3):1369-1371. PubMed ID: 36309603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
    Naik KB; Liu Y; Goodman M; Gillespie TW; Pickens A; Force SD; Steuer CE; Owonikoko TK; Ramalingam SS; Higgins K; Beitler JJ; Shin DM; Willingham FF; El-Rayes B; Landry JC; Fernandez FG; Saba NF
    Cancer; 2017 Sep; 123(18):3476-3485. PubMed ID: 28464264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of Tissue Microarray in Esophageal Squamous Cell Carcinoma.
    Lam AK; Lor DK
    Methods Mol Biol; 2020; 2129():119-135. PubMed ID: 32056174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histopathological Assessment for Esophageal Squamous Cell Carcinoma.
    Lam AK
    Methods Mol Biol; 2020; 2129():7-18. PubMed ID: 32056166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
    Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
    Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.